DEA revokes Washington doctor's registration to handle controlled substances
Published Date: 10/26/2026
Notice
Summary
Vida Janson, M.D., lost her license to handle controlled substances in Washington State, so the DEA has officially revoked her registration to prescribe or dispense these drugs. This means she can no longer legally work with controlled substances, effective immediately. If you’re a healthcare provider or patient in Washington, this change ensures only authorized professionals handle these medications.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
DEA Revokes Dr. Janson's Controlled-Substance Registration
If you are a patient or healthcare provider in Washington, Vida Janson, M.D. (DEA Certificate No. BJ6418380) had her DEA registration revoked and therefore can no longer lawfully prescribe, dispense, or handle controlled substances in Washington effective November 25, 2026. The Order notes her Washington medical license was suspended effective January 23, 2026, and DEA also denied any pending applications by Dr. Janson to renew, modify, or obtain additional registration in Washington.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-21725, Barry Backiewicz, D.D.S.; Decision and Order
Dr. Barry Backiewicz from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t ask for a hearing to challenge this, so the decision to revoke his registration is final. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
2026-21410, Youmna Abdulhadi, M.D.; Decision and Order
Dr. Youmna Abdulhadi from California lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration as of June 30, 2026. This means she can’t prescribe or manage controlled drugs anymore, affecting her medical practice and patients.
Previous / Next Documents
Previous: 2026-21798, Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
The Federal Trade Commission wants to keep its Fuel Rating Rule going for three more years, which helps gas sellers and makers share clear info about fuel quality. This affects fuel refiners, importers, distributors, and retailers who spend time and money keeping records and sharing fuel ratings. If you have thoughts, you’ve got until November 25, 2026, to speak up!
Next: 2026-21800, Agency Information Collection Activity: Maintenance of Records Under 38 CFR 36.4333
The Veterans Benefits Administration is asking for public feedback on keeping records under a current rule, with no changes planned. This helps them stay organized and efficient while following the law. If you want to share your thoughts, you have until December 28, 2026, to comment online.